• EZ Cap™ Human PTEN mRNA (ψUTP) Workflow Guide

  2026-08-28

  Build reproducible PTEN gain-of-function assays with a Cap 1, pseudouridine-modified transcript designed for efficient mammalian translation. This guide connects cell-based pathway studies with nanoparticle delivery experiments, including practical controls, starting parameters, and troubleshooting strategies for cancer research.

• MTT Assays: From Metabolic Signal to Translation

  2026-08-28

  A mechanistic and strategic guide to using MTT as a metabolic readout in cell proliferation, viability, and translational cancer research, with practical recommendations for interpreting assay signal in complex coculture models.

• Tubastatin A in Porcine Cardiac Arrest Injury

  2026-08-27

  A 2025 porcine study examined Tubastatin A after cardiac arrest and cardiopulmonary resuscitation, linking treatment with improved myocardial function, lower cardiac injury markers, and reduced signatures of GSDME-associated pyroptosis and MLKL-associated necroptosis. Its main contribution is a clinically relevant post-resuscitation intervention model, although the proposed HDAC6-dependent mechanism remains associative because direct target engagement was not established.

• Deferasirox, Mitochondrial ROS, and Myelopoiesis

  2026-08-27

  The reference study shows that deferasirox affects myeloid maturation in a stage-dependent manner through mitochondrial reactive oxygen species and NF-κB-associated transcriptional programs. Its combination of murine and human models, hypoxia experiments, and single-cell transcriptomics provides a framework for interpreting both hematologic benefits and potential neutrophil-related toxicity.

• iRhom2 in Olfaction: OR Regulation and Adaptation

  2026-08-26

  Azzopardi and colleagues identify iRhom2 as a selectively expressed regulator in olfactory sensory neurons and connect it to odorant receptor transcription, activity-dependent gene responses, and ADAM17-linked signaling. The findings support a feedback model in which odor stimulation reduces iRhom2 expression while iRhom2 may help shape olfactory receptor adaptation.

• RRP Restores Lipid Metabolism in Hepatic IRI

  2026-08-26

  A Journal of Ethnopharmacology study shows that Radix Rehmanniae Praeparata extracts alleviate hepatic ischemia-reperfusion injury by correcting hepatocyte lipid imbalance. Its central mechanistic advance is the linkage of AMPK activation with reduced SREBP2-dependent cholesterol synthesis and enhanced LXRα-mediated cholesterol efflux.

• Everolimus (RAD001) Workflows for Cancer Assays

  2026-08-25

  Everolimus (RAD001) provides a mechanistically defined way to interrogate mTOR-dependent growth, while paired viability and cell-death measurements reveal whether a response reflects proliferation arrest, killing, or both. This guide translates the compound’s formulation characteristics into reproducible cancer assays, translational comparisons, and troubleshooting decisions.

• Cholecystokinin octapeptide ammonium: Lab Guide

  2026-08-25

  Cholecystokinin octapeptide ammonium, also called CCK-8 ammonium, supports receptor-dissection studies spanning opioid-withdrawal anxiety, neuronal survival, immune signaling, and cardiac hormone release. This practical guide emphasizes sulfated-peptide handling, dose selection, antagonist controls, and cross-model troubleshooting.

• Saquinavir A3790: Reliable Viability Assays

  2026-08-24

  Saquinavir (SKU A3790) supports controlled HIV protease inhibitor, permeability, and exploratory cytotoxicity workflows through defined formulation, storage, and quality documentation. This scenario-based guide explains how to reduce vehicle, exposure, interpretation, and reagent-selection errors without overstating evidence for cancer applications.

• ML365 and NLRP3 Signaling in Aged-Mouse POCD

  2026-08-24

  A 2024 mouse study found that ML365 pretreatment reduced postoperative cognitive impairment, hippocampal NLRP3 inflammasome markers, tissue injury, and systemic oxidative stress after exploratory laparotomy in aged mice. The work provides a pharmacological link between K2P channel biology and postoperative neuroinflammation, while leaving direct TASK1 causality and therapeutic translation to be established.

• STL427944 Targets FOXM1 to Reverse Chemoresistance

  2026-08-23

  The reference study identifies STL427944 through gene network analysis and shows that it suppresses the oncogenic transcription factor FOXM1 by relocating it from the nucleus to the cytoplasm for autophagic degradation. This mechanism sensitizes human cancer cells to platinum agents, 5-fluorouracil, and taxanes, providing a mechanistic framework for combination-oriented cancer research.

• Resveratrol as a SIRT1 Activator in Neuroprotection

  2026-08-22

  Resveratrol provides a practical way to test SIRT1-linked mitochondrial rescue in prion peptide-treated N2a cells, while also supporting complementary neurotoxicity models. This guide translates the SIRT1–PGC-1α–TFAM finding into a controlled workflow with dose planning, orthogonal readouts, and troubleshooting safeguards.

• 2'3'-cGAMP Workflows for STING and Radiotherapy

  2026-08-22

  Use 2'3'-cGAMP (sodium salt) as a defined STING agonist control to separate receptor-level signaling from variable cGAS activity. This guide translates new evidence on ABCC10-mediated cGAMP efflux into practical radiotherapy-resistance assays, conditioned-media experiments, and troubleshooting decisions.

• Indometacin Sodium: Assay Workflows & Optimization

  2026-08-21

  Build more informative inflammation assays with Indometacin Sodium, from COX-driven prostaglandin synthesis inhibition to Wnt/β-catenin-linked remyelination models. This guide pairs practical dosing, controls, and troubleshooting with the reference study’s mechanistic workflow.

• Indometacin Sodium Trihydrate: Mechanism & Protocols

  2026-08-20

  Indometacin Sodium Trihydrate is a trihydrated sodium salt of indomethacin and a nonselective COX-1 and COX-2 inhibitor used in anti-inflammatory research. Its reported applications span inflammation assays, prostaglandin synthesis inhibition, pancreatic stellate cell studies, oligodendrocyte differentiation, and selected reproductive protocols.

7949 records 1/530 page Next 12345 下5页 Last page